A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
Andrew H. Karaba(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Yolanda Eby(Johns Hopkins University), Kristy Wang(Johns Hopkins University), Aura T. Abedon(Johns Hopkins University), Joel N. Blankson(Johns Hopkins University), Olivia Akinde(Johns Hopkins University), Dorry L. Segev(New York University), Elizabeth A. Thompson(North Carolina State University), Ioannis Sitaras(Johns Hopkins University), Sabra L. Klein(Johns Hopkins University), Alex G. Rittenhouse(Johns Hopkins University), Daniel Warren(Johns Hopkins University), Jacqueline Garonzik‐Wang(University of Wisconsin–Madison), Andrew Pekosz(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Jessica E. Ruff(Johns Hopkins University), Jennifer L. Alejo(Johns Hopkins University), Xianming Zhu(Johns Hopkins University), Brian J. Boyarsky(Johns Hopkins University), Justin R. Bailey(Johns Hopkins University), Andrea L. Cox(Johns Hopkins University), Tao Liang(Johns Hopkins University)
Cited by 103
Related Papers
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Impact of sex and gender on COVID-19 outcomes in Europe
|Biology of Sex Differences|2020|1.4k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k